OHI · Omega Healthcare Investors
50 filings
OHI 10-Q Quarterly Reports
Omega Healthcare Investors - 50 quarterly reports
OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.
- 8-K · Jan 8, 2016
- 8-K · Feb 3, 2016
- 8-K · Feb 10, 2016
- 10-K · Feb 29, 2016
- 8-K · Mar 23, 2016
- 8-K · May 4, 2016
- 10-Q · May 6, 2016
- 8-K · Jun 13, 2016
- 8-K · Jun 30, 2016
- 8-K · Jul 5, 2016
- 8-K · Jul 12, 2016
- 8-K · Aug 2, 2016
- 10-Q · Aug 5, 2016
- 8-K · Oct 31, 2016
- 10-Q · Nov 8, 2016
- 8-K · Jan 13, 2017
- 8-K · Feb 8, 2017
- 10-K · Feb 24, 2017
- 8-K · Mar 29, 2017
- 8-K · Apr 4, 2017
- 8-K · May 3, 2017
- 10-Q · May 5, 2017
- 8-K · May 31, 2017
- 8-K · Jun 9, 2017
- 8-K · Jul 26, 2017
- 10-Q · Aug 9, 2017
- 10-Q/A · Aug 9, 2017
- 10-K/A · Aug 9, 2017
- 8-K · Oct 30, 2017
- 10-Q · Nov 7, 2017
- 8-K · Dec 22, 2017
- 8-K · Feb 13, 2018
- 10-K · Feb 23, 2018
- 8-K · May 1, 2018
- 8-K · May 7, 2018
- 10-Q · May 10, 2018
- 8-K · Jun 11, 2018
- 8-K · Aug 3, 2018
- 10-Q · Aug 8, 2018
- 8-K · Sep 7, 2018
- 8-K · Oct 25, 2018
- 8-K · Nov 2, 2018
- 8-K · Nov 5, 2018
- 10-Q · Nov 7, 2018
- 8-K · Dec 20, 2018
- 8-K · Jan 4, 2019
- 8-K · Feb 6, 2019
- 8-K · Feb 11, 2019
- 10-K · Feb 26, 2019
- 8-K · May 7, 2019
- 10-Q · May 9, 2019
- 8-K · May 17, 2019
- 8-K · Jun 11, 2019
- 8-K · Aug 6, 2019
- 10-Q · Aug 8, 2019
- 8-K · Sep 12, 2019
- 8-K · Sep 20, 2019
- 8-K · Nov 5, 2019
- 10-Q · Nov 8, 2019
- 8-K · Dec 20, 2019
- 8-K · Jan 2, 2020
- 8-K · Feb 5, 2020
- 10-K · Feb 28, 2020
- 8-K · Mar 25, 2020
- 8-K · Mar 31, 2020
- 8-K · May 4, 2020
- 10-Q · May 8, 2020
- 8-K · Jun 11, 2020
- 8-K · Jul 14, 2020
- 8-K · Aug 5, 2020
- 10-Q · Aug 7, 2020
- 8-K · Sep 24, 2020
- 8-K · Oct 9, 2020
- 8-K · Oct 23, 2020
- 8-K · Oct 29, 2020
- 10-Q · Nov 3, 2020
- 8-K · Jan 6, 2021
- 8-K · Feb 4, 2021
- 10-K · Feb 22, 2021
- 8-K · Mar 3, 2021
- 8-K · Mar 4, 2021
- 8-K · Mar 4, 2021
- 8-K · Mar 10, 2021
- 8-K · Mar 18, 2021
- 8-K · Apr 14, 2021
- 8-K · May 3, 2021
- 8-K · May 4, 2021
- 10-Q · May 4, 2021
- 8-K · May 20, 2021
- 8-K · Jun 3, 2021
- 8-K · Jun 8, 2021
- 8-K · Aug 2, 2021
- 8-K · Aug 2, 2021
- 10-Q · Aug 3, 2021
- 8-K · Aug 5, 2021
- 8-K · Sep 21, 2021
- 8-K · Nov 4, 2021
- 10-Q · Nov 5, 2021
- 8-K · Jan 4, 2022
- 8-K · Jan 27, 2022
- 8-K · Feb 2, 2022
- 10-K · Feb 17, 2022
- 8-K · Apr 4, 2022
- 8-K · May 2, 2022
- 10-Q · May 3, 2022
- 8-K · Jun 6, 2022
- 8-K · Aug 1, 2022
- 10-Q · Aug 2, 2022
- 8-K · Oct 21, 2022
- 8-K · Nov 2, 2022
- 10-Q · Nov 3, 2022
- 8-K · Jan 3, 2023
- 8-K · Jan 9, 2023
- 8-K · Feb 2, 2023
- 10-K · Feb 14, 2023
- 8-K · May 2, 2023
- 10-Q · May 3, 2023
- 8-K · Jun 5, 2023
- 8-K · Aug 2, 2023
- 10-Q · Aug 3, 2023
- 8-K · Aug 11, 2023
- 8-K · Nov 2, 2023
- 10-Q · Nov 3, 2023
- 8-K · Dec 4, 2023
- 8-K · Jan 2, 2024
- 8-K · Feb 7, 2024
- 10-K · Feb 12, 2024
- 8-K · Mar 12, 2024
- 8-K · Mar 14, 2024
- 8-K · Apr 15, 2024
- 8-K · May 2, 2024
- 10-Q · May 3, 2024
- 8-K · Jun 3, 2024
- 8-K · Jun 7, 2024
- 8-K · Aug 1, 2024
- 10-Q · Aug 2, 2024
- 8-K · Sep 6, 2024
- 8-K · Oct 30, 2024
- 10-Q · Oct 31, 2024
- 8-K · Jan 6, 2025
- 8-K · Feb 5, 2025
- 10-K · Feb 13, 2025
- 8-K · May 1, 2025
- 10-Q · May 2, 2025
- 8-K · May 12, 2025
- 8-K · Jun 2, 2025
- 8-K · Jun 6, 2025
- 8-K · Jun 6, 2025
- 8-K · Jun 11, 2025
- 8-K · Jun 20, 2025
- 8-K · Jul 10, 2025
- 8-K · Jul 31, 2025
- 10-Q · Aug 1, 2025
- 8-K · Sep 15, 2025
- 8-K · Oct 1, 2025
- 8-K · Oct 15, 2025
- 8-K · Oct 30, 2025
- 10-Q · Oct 31, 2025
- 8-K · Nov 3, 2025
- 8-K · Jan 7, 2026
- 8-K · Feb 4, 2026
- 10-K · Feb 9, 2026
- 8-K · Apr 28, 2026
- 10-Q · Apr 29, 2026
- 8-K · May 21, 2026
- 8-K · Jun 5, 2026
- 8-K · Jul 29, 2026
- 10-Q · Jul 30, 2026
- 8-K · Oct 1, 2026
- 8-K · Oct 5, 2026
- 8-K · Nov 3, 2026
- 10-Q · Nov 4, 2026
- 2026-Q3Nov 4, 2026
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2026
Omega Healthcare Investors, Inc. ("Parent"), a Maryland REIT with operations in the U.S., U.K. and Canada, reported net income of $86.8 million for the third quarter of 2026, down from $185.0 million in the same period of 2025, and net income available to common stockholders of $83.1 million, or $0.27 per diluted share, versus $0.59 a year earlier. For the nine months ended September 30, 2026, net income was $625.1 million ($1.92 diluted EPS), driven largely by a $249.1 million net gain on assets sold from the sale of 31 facilities. Total revenues rose to $340.6 million for the quarter from $311.6 million, with new resident fees and services of $30.8 million from the Company's RIDEA-structured Operating segment. Quarterly results were weighed down by $59.9 million of acquisition, merger and transition related costs, tied largely to the acquisition of operators of 30 U.K. care homes, and $39.6 million of general and administrative expense, which included non-cash stock-based compensation tied to leadership transitions. The balance sheet grew to $10.12 billion in total assets at September 30, 2026, with total equity of $5.76 billion and senior notes and other unsecured borrowings of $4.02 billion. Cash and cash equivalents increased to $195.9 million, and the revolving credit facility balance was zero, versus $242.0 million at year-end 2025. Management reports $2.0 billion of availability under its revolving credit facility and $1.8 billion of remaining ATM Program capacity. Operating cash flow for the nine months was $624.2 million. The company paid $605.4 million in common dividends during the nine months and declared a $0.68 per share dividend on October 26, 2026, payable November 16, 2026. Several subsequent events are disclosed. On October 1, 2026, the Company completed the transition of a 32-SNF Florida portfolio to PACS Group, Inc., paying a $90.0 million lease termination fee, with new initial annual contractual rent of $58.0 million under the PACS lease. Genesis's sale to NewGen closed on October 14, 2026, and the DIP loan and secured term loan claims were repaid in October 2026. The Company also funded a £631.7 million mortgage loan in November 2026 secured by the Runwood Portfolio, and it acquired a Georgia continuing care retirement community for $50.5 million on November 2, 2026. Leadership is also changing: Matthew P. Gourmand becomes President and CEO effective October 1, 2026, succeeding C. Taylor Pickett.
- 2026-Q2Jul 30, 2026
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2026
Omega Healthcare Investors, Inc. reported net income of $379.7 million for the quarter ended June 30, 2026, compared with $140.5 million in the prior-year quarter, and net income available to common stockholders of $362.8 million, or $1.19 diluted earnings per share. Results were lifted by gains on asset sales of $246.5 million, driven mainly by the sale of 26 facilities in the quarter for total consideration of $562.6 million. Total revenues rose to $328.2 million from $282.5 million, led by rental income of $266.5 million and the first resident fees and services of $14.0 million from the new Operating segment. Net operating income (a non-GAAP measure) was $330.9 million, of which Triple-Net contributed $324.5 million and Operating $5.4 million. The balance sheet shows total assets of $10.01 billion, total equity of $5.64 billion and a revolving credit facility balance reduced to $6.0 million from $242.0 million at year-end 2025. Cash and cash equivalents were $39.0 million, and restricted cash rose to $145.2 million, including $117.7 million held by qualified intermediaries for pending 1031 exchanges. Operating cash flow for the six months was $433.2 million. The company also disclosed a leadership transition: CEO C. Taylor Pickett steps down October 1, 2026, with Matthew P. Gourmand succeeding him, and Robert O. Stephenson's employment ends August 1, 2026, with Neal A. Ballew becoming CFO. Management expects $31.8 million of incremental non-cash stock-based compensation tied to these arrangements, with a further $17.1 million expected in the third quarter. Credit and concentration items remain central to the outlook. Twenty-two operators were on a cash basis of rental revenue recognition, representing 22.2% of total revenues for the six months ended June 30, 2026. The Maplewood revolver, with an amortized cost of $263.6 million, is on non-accrual, and the Genesis bankruptcy continues, with the company's two secured term loans totaling $139.8 million expected to be satisfied upon plan effectiveness. The Board declared a quarterly dividend of $0.68 per share payable August 14, 2026.
- 2026-Q1Apr 29, 2026
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2026
Omega Healthcare Investors, Inc. reported first-quarter 2026 total revenues of $322.955 million, up from $276.785 million a year earlier, with rental income of $270.617 million and net income available to common stockholders of $151.049 million ($0.47 basic and diluted EPS, versus $0.34 basic and $0.33 diluted in Q1 2025). Growth was driven mainly by higher rental income from facility acquisitions, lease escalations, cash-basis operator payments (primarily Maplewood) and a stronger British Pound, partially offset by lower gains on asset sales ($3.0 million versus $10.1 million) and lower G&A, which benefited from a $6.6 million non-cash stock compensation charge in Q1 2025. Nareit FFO was $249.496 million versus $183.778 million in the prior-year quarter. The balance sheet expanded, with total assets of $10.23 billion at March 31, 2026, and the company drew more heavily on its revolver, which stood at $425.0 million versus $242.0 million at year-end 2025. Total unsecured borrowings were $4.44 billion, and the filing states that debt represented 45.1% of total capitalization. The company acquired 15 facilities for $126.4 million, made a $92.8 million investment for a 9.9% interest in Saber Healthcare Holdings, LLC, and issued 2.2 million shares through its ATM program for $106.7 million gross proceeds. Operating cash flow was $215.5 million. Credit and operator risk remain central. Twenty operators, representing 21.8% of total revenues for the quarter, were on a cash basis for rental revenue recognition. Maplewood remains on cash basis and non-accrual status, and Genesis is in Chapter 11, where the company has extended a Super-Priority DIP Loan of which $25.0 million was outstanding at quarter-end. A sale of Genesis' assets to WSSH is pending, with closing not expected before June 30, 2026. The company also declared a $0.67 per share dividend on April 23, 2026, payable May 15, 2026.
- 2025-Q3Oct 31, 2025
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2025
Omega Healthcare Investors, Inc. reported net income available to common stockholders of $179.7 million, or $0.59 diluted per share, for the three months ended September 30, 2025, compared with $111.8 million, or $0.42 diluted per share, a year earlier. For the nine months, net income available to common stockholders was $425.4 million, or $1.39 diluted per share, versus $293.0 million, or $1.14 diluted per share, in the prior-year period. Total revenues were $311.6 million for the quarter and $870.9 million for the nine months. Nareit FFO was $241.8 million for the quarter and $639.1 million for the nine months, compared with $196.1 million and $538.3 million a year earlier. The company's balance sheet grew over the period. Total assets were $10.6 billion at September 30, 2025, and total debt was $5.0 billion, representing 48.9% of total capitalization. Operating cash flow was $647.9 million for the nine months. Omega issued 8.8 million shares through its dividend reinvestment plan and 7.5 million through its at-the-market program during the nine months, and it acquired 66 facilities for $637.9 million. In September 2025 it replaced its $1.45 billion revolver with a $2.0 billion revolving credit facility and a $300.0 million delayed draw term loan. In October 2025 it redeemed $600.0 million of 5.250% senior notes at par. Credit quality remains a key watch item. Maplewood, which is on a cash basis and on non-accrual for interest on its $320 million revolver, paid $15.3 million of contractual rent for the quarter against $17.3 million due. Subsequent to quarter-end, the company entered into a joint venture with affiliates of Saber Healthcare Holdings and agreed to acquire a 9.9% equity interest in Saber for $92.6 million in cash, with closing expected January 1, 2026.
- 2025-Q2Aug 1, 2025
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2025
Omega Healthcare Investors, Inc. (Parent, a Maryland corporation, with its consolidated subsidiaries referred to as "Omega" or the "Company") reported its quarterly results for the period ended June 30, 2025 in this Form 10-Q. For the three months ended June 30, 2025, total revenues were $282.5 million versus $252.7 million a year earlier, and net income available to common stockholders was $136.6 million, or $0.46 per diluted share, compared with $113.9 million, or $0.45 per diluted share, in the prior-year quarter. For the six months ended June 30, 2025, net income available to common stockholders was $245.6 million, or $0.79 per diluted share. Rental income for the six months rose to $471.4 million from $421.2 million, and total assets reached $10.55 billion at June 30, 2025. The Company expanded its portfolio during the period, acquiring 63 facilities for $560.4 million in the six months ended June 30, 2025, including a 45-facility acquisition in the U.K. and Jersey for $344.2 million. It sold 34 facilities for $183.0 million in net cash proceeds and issued $600 million of 5.200% Senior Notes due 2030 in June 2025. Common shares outstanding rose to 293.1 million at June 30, 2025, and the Company paid $383.8 million in dividends during the six months. Cash and cash equivalents stood at $734.2 million at quarter end. Credit quality remained a concern. Maplewood is on a cash basis and short-paid rent, and its $320 million revolver is on non-accrual with no interest income recognized in the period. LaVie's plan of reorganization took effect June 1, 2025, and Genesis Healthcare filed for Chapter 11 in July 2025, after the period end, with the Company committing up to $8.0 million to a $30.0 million DIP financing. Twenty-two operators were on a cash basis of revenue recognition, representing 17.5% of total revenues for the six months ended June 30, 2025.
- 2025-Q1May 2, 2025
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2025
Omega Healthcare Investors, Inc. ("Parent"), a Maryland REIT with an UPREIT structure, reported net income of $112.1 million for the three months ended March 31, 2025, up from $69.3 million a year earlier, and net income available to common stockholders of $109.0 million, or $0.33 per diluted share, versus $0.27 in the prior-year quarter. Total revenues rose to $276.8 million from $243.3 million, driven mainly by higher rental income ($232.2 million vs. $206.9 million) and interest income ($43.1 million vs. $35.8 million). Results were supported by a $10.1 million net gain on the sale of 27 facilities for $120.9 million in net cash proceeds, partly offset by a $10.0 million lease inducement to a cash-basis operator recorded as a reduction of rental income and $6.6 million of non-cash stock-based compensation tied to a leadership transition. The balance sheet shrank over the quarter, with total assets of $9.71 billion versus $9.90 billion at December 31, 2024, as the company repaid $400 million of 4.50% senior notes at maturity and reduced cash to $368.0 million. Total debt was $4.45 billion, with a weighted average annual interest rate of 4.6% and 94.7% of debt with outstanding principal having fixed interest payments after swaps. Equity financing was substantial: the company issued 4.4 million shares under its ATM program for $164.4 million gross and 2.7 million shares through its dividend reinvestment plan for $99.8 million gross. Subsequent to quarter end, the company closed an acquisition of 45 U.K. and Jersey facilities for total consideration of £259.8 million. Operator credit quality remained the central risk. Twenty operators were on a cash basis of revenue recognition, representing 18.6% of total revenues for the quarter. Maplewood short-paid $6.0 million of $19.6 million due in the quarter and short-paid a further $2.1 million in April 2025; its $320 million revolver is on non-accrual, with the amortized cost basis of $263.6 million and an internal risk rating of 5. Genesis failed to make its March 2025 rent and one loan interest payment, and LaVie is in Chapter 11 with a confirmed plan. Management reported that disclosure controls were effective as of March 31, 2025.
- 2024-Q3Oct 31, 2024
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2024
Omega Healthcare Investors, Inc. ("Parent") reported its Form 10-Q for the quarter ended September 30, 2024. Total revenues for the three months ended September 30, 2024 were $276.0 million, up from $242.0 million a year earlier, and net income available to common stockholders was $111.8 million, or $0.42 per diluted share, versus $91.4 million, or $0.37, in the prior-year quarter. For the nine months, revenues were $772.1 million and net income available to common stockholders was $293.0 million ($1.14 diluted EPS). Nareit FFO was $196.1 million for the quarter and $538.3 million for the nine months, compared with $161.0 million and $462.3 million in the prior-year periods. Gains on asset sales were much smaller in 2024 ($11.3 million for the nine months versus $70.0 million in 2023), so the earnings improvement is driven largely by rental and interest income growth. The company's balance sheet grew to $9.57 billion in total assets at September 30, 2024, supported by about $801.2 million of common stock issuance over the nine months and the July 2024 acquisition of the remaining 51% interest in the Cindat Joint Venture, which added 63 U.K. facilities. Total debt was $4.86 billion, and the filing states that $400 million of 4.50% senior notes mature in January 2025, which management expects to repay using cash, the $1.45 billion revolver and the 2024 ATM program. Cash and cash equivalents were $342.4 million. Operator credit concerns remain the central risk. Maplewood's $263.6 million revolving loan, 18.9% of real estate loan amortized cost, is subject to a settlement and transition that still requires regulatory approvals, and the filing notes a substantial loss is possible if the transition is not completed. LaVie entered Chapter 11 in June 2024, and 18 operators were on a cash basis of revenue recognition, representing 18.6% of nine-month revenues. Quarterly dividends were maintained at $0.67 per share, with a dividend declared October 25, 2024.
- 2024-Q2Aug 2, 2024
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2024
Omega Healthcare Investors, Inc. reported net income available to common stockholders of $113.9 million, or $0.46 per basic share, for the three months ended June 30, 2024, compared with $59.9 million, or $0.25 per share, in the prior-year quarter. For the six months, net income available to common stockholders was $181.2 million ($0.73 basic per share). Total revenues were $252.7 million for the quarter and $496.0 million for the six months, and Nareit FFO was $189.1 million for the quarter and $342.2 million for the six months. Total assets were $8.85 billion at June 30, 2024, with cash and cash equivalents down to $35.2 million from $442.8 million at December 31, 2023, after repayment of $400 million of 4.95% senior notes in April 2024. The filing highlights significant credit concerns tied to operators. Maplewood Senior Living is short-paying rent, and Omega accelerated its $291.2 million revolving credit facility after issuing a May 2024 demand letter; a settlement agreement dated July 31, 2024 is subject to probate court and regulatory approvals. The amortized cost basis of the Maplewood loan was $263.6 million, or 18.0% of total real estate loans receivable. LaVie Care Centers filed Chapter 11 in June 2024, and Omega committed $10 million of a $20 million DIP financing facility, with a $7.8 million credit loss provision recorded in the quarter on LaVie loans. Eighteen operators were on a cash basis of revenue recognition, representing 18.6% of total revenues for the six months. Subsequent to quarter-end, Omega acquired the remaining 51% interest in the Cindat Joint Venture for $97.4 million in cash, assuming a $243.2 million mortgage loan, and the company declared a $0.67 per share dividend payable August 15, 2024.
- 2024-Q1May 3, 2024
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2024
Omega Healthcare Investors, Inc. ("Parent"), a Maryland REIT that invests in healthcare real estate in the U.S. and U.K., reported net income of $69.3 million for the quarter ended March 31, 2024, compared with $36.8 million in the prior-year quarter. Net income available to common stockholders was $67.4 million, or $0.27 per diluted share, versus $0.15 a year earlier. Total revenues rose to $243.3 million from $218.2 million, driven mainly by rental income of $206.9 million and interest income of $35.8 million. The prior-year quarter included a $12.5 million Maplewood option termination fee that reduced rental income, which partly explains the year-over-year rental income increase. Credit quality remained a central theme. Twenty operators were on a cash basis of revenue recognition, representing 18.4% of total revenues for the quarter. Maplewood short-paid rent, and its loan was moved to a higher internal risk rating, contributing to a provision for credit losses of $8.5 million. Total impairments were $5.3 million, and the allowance for credit losses on total loans and commitments rose to $229.8 million. Total assets were $9.01 billion, total debt was $5.03 billion, and cash and cash equivalents were $361.8 million. Subsequent to quarter end, the company repaid the $400 million 4.95% senior notes due April 1, 2024, using cash and revolver proceeds. The company also raised $32.4 million of gross proceeds through its ATM program and DRIP and declared a $0.67 per share dividend payable May 15, 2024. Management stated it expects its sources of liquidity to fund cash needs over the next twelve months and noted that the 2025 senior notes maturity can be addressed with existing liquidity sources.
- 2023-Q3Nov 3, 2023
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2023
Omega Healthcare Investors, Inc. ("Parent"), a Maryland REIT that invests in healthcare real estate in the U.S. and U.K., reported net income available to common stockholders of $91.4 million ($0.37 per diluted share) for the three months ended September 30, 2023, compared with $102.3 million ($0.43) a year earlier. For the nine months, net income available to common stockholders was $187.2 million ($0.78 per diluted share), versus $381.3 million ($1.60) in the prior-year period. Total revenues were $242.0 million for the quarter and $710.4 million for the nine months. Gains on asset sales were $44.1 million in the quarter and $70.0 million year to date, while impairments on real estate properties totaled $27.9 million and $88.0 million for the same periods. The filing shows continued operator stress. Eighteen operators were on a cash basis of revenue recognition as of September 30, 2023, representing 25.1% of total revenues (excluding write-offs) for the nine months. Maplewood short-paid rent in multiple months, Guardian did not pay rent in August and September, and LaVie paid $7.4 million against $20.7 million due in the third quarter. The company also restructured several operator relationships and extended significant loans. Total assets were $9.43 billion and total equity $3.86 billion at September 30, 2023, with total debt of $5.29 billion. Cash and cash equivalents rose to $554.7 million, supported by a new $400 million 2025 senior unsecured term loan (upsized by $28.5 million) and the repayment of $350 million of 4.375% notes due August 2023. Subsequent to quarter end, the company sold 29 facilities previously leased to LaVie for $305.2 million in purchase consideration, consisting of $91.9 million in gross cash proceeds and $213.3 million in HUD mortgage pay-offs, and amended the LaVie master lease to reduce monthly rent to $3.4 million. The Board declared a $0.67 per share quarterly dividend payable November 15, 2023.
- 2023-Q2Aug 3, 2023
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2023
Omega Healthcare Investors, Inc. (Parent, a Maryland corporation that elected REIT status) reported results for the quarter ended June 30, 2023 in this Form 10-Q. Total revenues were $250.2 million for the three months and $468.4 million for the six months, versus $244.6 million and $494.0 million a year earlier. Net income available to common stockholders was $59.9 million ($0.25 per diluted share) for the quarter, compared with $89.5 million ($0.38) in the prior-year quarter. The six-month figure was $95.8 million ($0.40 diluted), down from $279.1 million ($1.17). The year-over-year decline mainly reflects lower gains on asset sales ($25.9 million for six months versus $138.8 million) and higher impairments ($60.1 million versus $11.2 million). Cash-basis operators, including Maplewood and LaVie, also contributed to lower rental income. Net cash provided by operating activities was $281.7 million for the six months. The filing describes continued operator stress tied to labor costs, occupancy recovery and the end of the federal public health emergency on May 11, 2023. Eighteen operators were on a cash basis of revenue recognition as of June 30, 2023, representing 25.8% of total revenues (excluding write-offs) for the six months. Several restructurings were completed in the first half of 2023, including with Agemo, LaVie and Maplewood. Maplewood short-paid rent in June and July 2023 by $1.0 million each, and LaVie short-paid $4.7 million in July 2023. The company's total allowance for credit losses was $185.5 million at June 30, 2023. Management reports that the Securities Class Action settlement became effective May 25, 2023, and the company reversed a $31 million legal reserve in the second quarter. Liquidity appears solid on the face of the filing. Cash and cash equivalents were $350.7 million, and the company had $1.43 billion of availability under its revolving credit facility. Total debt was $5.3 billion, and the company stated that 99% of its debt with outstanding principal has fixed interest payments. On August 1, 2023, the company repaid $350 million of 4.375% senior notes using available cash. It also declared a $0.67 per share dividend on July 20, 2023, payable August 15, 2023. The company sold 6.5 million shares under its ATM Program in the first half of 2023 for gross proceeds of $199.4 million and had $730.5 million of potential sales remaining under that program.
- 2023-Q1May 3, 2023
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2023
Omega Healthcare Investors, Inc. ("Parent") reported net income available to common stockholders of $35.9 million, or $0.15 per diluted share, for the three months ended March 31, 2023, compared with $189.6 million, or $0.79 per share, in the first quarter of 2022. Total revenues fell to $218.2 million from $249.3 million, driven mainly by a decrease in rental income to $189.1 million from $216.9 million. The prior-year quarter included a $113.6 million gain on asset sales tied to the Gulf Coast exit, versus a $13.6 million gain in 2023. Impairments rose to $39.0 million from $3.5 million, and a $12.5 million one-time Maplewood option termination fee reduced rental income. Nareit FFO was $146.1 million compared with $170.7 million a year earlier. Collectibility remains the central theme. As of March 31, 2023, 17 operators were on a cash basis of revenue recognition, representing 25.1% of total revenues (excluding write-offs). The company restructured its exposures to Agemo, LaVie, Maplewood and Healthcare Homes, and deferred $24.4 million of contractual rent and interest for eight operators during the quarter. Total debt was $5.3 billion, with a weighted average interest rate of 4.1% and 98% of debt at fixed rates. Cash and cash equivalents were $245.2 million, and the company had $1.43 billion of revolving credit availability. The filing states that the company anticipates repaying its $350 million 4.375% senior notes due August 2023 using available cash and revolver proceeds. Subsequent to quarter end, the company committed $222.6 million to a West Virginia transaction involving four SNFs acquired directly and five loans to finance the acquisition of 13 more, and it sold five Guardian facilities for $23.8 million in estimated gross proceeds. The company also declared a $0.67 per share quarterly dividend, payable May 15, 2023. A securities class action settlement of $30.75 million was approved on April 25, 2023, and is funded by insurance, with no impact on the statement of operations.
- 2022-Q3Nov 3, 2022
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2022
Omega Healthcare Investors, Inc. (Parent), a Maryland corporation and REIT, reported third-quarter 2022 results in this Form 10-Q for the period ended September 30, 2022. Total revenues for the three months were $239.4 million, down from $281.7 million, and net income available to common stockholders was $102.3 million, or $0.43 per diluted share. For the nine months, total revenues were $733.4 million and net income available to common stockholders was $381.3 million. Rental income fell year over year, driven by cash-basis operators including Agemo, the 1.4% Operator, and the 2.2% Operator, along with the Gulf Coast and Guardian restructurings. As of September 30, 2022, 17 operators were on a cash basis of revenue recognition, representing 15.3% of total revenues (excluding write-offs) for the nine months. The balance sheet showed total assets of $9.48 billion and total equity of $3.90 billion at September 30, 2022. Cash and cash equivalents rose to $134.9 million from $20.5 million at year-end 2021. Total debt was $5.28 billion, and the weighted-average annual interest rate on debt was 4.1%. The company repurchased 5.2 million shares for $142.3 million during the nine months, under a $500 million authorization, with no repurchases in the third quarter. Dividends of $0.67 per share were declared for the quarter, and the company's Agemo lease and loan agreements remain in forbearance and ongoing restructuring negotiations. The filing also discloses an agreement in principle reached in October 2022 to settle the Securities Class Action, with a $31 million legal reserve recorded and an offsetting insurance receivable of $31 million, so there is no net impact on the statement of operations. Subsequent to quarter-end, the company sold 19 Agemo facilities for aggregate gross cash proceeds of $315.8 million.
- 2022-Q2Aug 2, 2022
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2022
Omega Healthcare Investors, Inc. (“Parent”), a Maryland REIT that invests in healthcare real estate in the U.S. and U.K., reported net income available to common stockholders of $89.5 million ($0.38 per diluted share) for the second quarter of 2022, compared with $84.5 million ($0.36) in the second quarter of 2021. For the six months ended June 30, 2022, net income available to common stockholders was $279.1 million ($1.17 per diluted share), versus $244.5 million ($1.04) a year earlier. Total revenues were $244.6 million for the quarter, down from $257.4 million, mainly reflecting lower rental income tied to the Agemo cash-basis operator, the Gulf Coast sale, and the Guardian restructuring. Gains on asset sales rose to $25.2 million for the quarter and $138.8 million for the six months, supported by the sale of 40 facilities in the first half of 2022. Collectibility remains a central concern. Agemo continued not to pay contractual rent and interest, and one operator representing a meaningful share of revenue was placed on a cash basis of revenue recognition, with approximately $8.3 million of straight-line rent receivables written off. A second operator was placed on a cash basis in June 2022 after expressing substantial doubt about its ability to continue as a going concern. Omega also entered a formal restructuring agreement with Guardian Healthcare, reducing combined annual rent and mortgage interest to $24.0 million beginning July 1, 2022 and allowing $18.0 million of deferred amounts. The Company recorded a $3.0 million legal reserve related to the Lakeway Hospital investigation by the Department of Justice. Balance sheet activity included total assets of $9.52 billion, total debt of $5.31 billion, and cash and cash equivalents of $164.9 million at June 30, 2022. The Company repurchased 5.2 million shares for $142.3 million in the first half under a $500 million authorization, and declared a $0.67 per share dividend on July 21, 2022. Investment activity included $108.5 million of acquisitions in the first half and $81.4 million of new other investment loans, including a $35.6 million mezzanine loan and a $25.0 million LaVie term loan.
- 2022-Q1May 3, 2022
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2022
Omega Healthcare Investors, Inc. (Parent) reported first-quarter 2022 results in its Form 10-Q, with total revenues of $249.3 million versus $273.8 million in the first quarter of 2021, and net income of $195.2 million versus $164.4 million. Net income available to common stockholders was $189.6 million, or $0.79 per diluted share, compared with $0.69 a year earlier. The results were lifted by gains on assets sold of $113.6 million, which offset lower rental income. Rental income fell to $216.9 million from $237.8 million, mainly due to cash-basis operators Agemo and Guardian, which paid no rent in the quarter, and to the absence of rent from 24 Gulf Coast facilities. The company sold 27 facilities for approximately $332.6 million in net cash proceeds during the quarter, primarily the 22 former Gulf Coast facilities, and reported a net gain of approximately $113.6 million. Cash and cash equivalents rose to $491.2 million at March 31, 2022, from $20.5 million at December 31, 2021. Total debt was $5.6 billion, with a weighted-average annual interest rate of 3.96%, and 92% of debt with outstanding principal balances carried fixed interest payments. The company repurchased 980,530 shares for $27.3 million under a newly authorized $500 million repurchase program, and declared a quarterly dividend of $0.67 per share. The filing highlights ongoing operator stress tied to COVID-19. In April 2022, the company entered a formal restructuring agreement with Guardian Healthcare, under which Guardian may defer up to $18.0 million of rent and interest and base rent and mortgage interest will be reduced to an aggregate $24.0 million once certain facility sales are completed. The filing also discloses a securities class action and a Department of Justice investigation related to the Lakeway Hospital joint venture, and states that the company believes the claims are without merit and that it cannot determine whether a loss is probable.
- 2021-Q3Nov 5, 2021
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2021
Omega Healthcare Investors, Inc. ("Parent") reported third-quarter 2021 results in this Form 10-Q, with total revenues of $281.7 million for the three months ended September 30, 2021, up from $119.2 million a year earlier, and net income available to common stockholders of $138.9 million, or $0.58 per diluted share, compared with a net loss of $91.3 million in the prior-year quarter. For the nine months, revenues were $812.9 million and net income available to common stockholders was $383.4 million, or $1.62 per diluted share. The company's Nareit FFO was $180.7 million for the quarter and $531.7 million for the nine months. Gains on asset sales were significant: 45 facilities were sold in the first nine months for $310.8 million in net cash proceeds, producing $160.6 million of net gains. Credit quality was the central concern. Agemo Holdings failed to pay rent and interest in August and September 2021 and missed October payments, and Gulf Coast Health Care stopped paying rent in the second quarter and filed for chapter 11 on October 14, 2021. Guardian failed to make October 2021 rent and interest payments on 26 leased facilities and a $112.5 million mortgage. Provision for credit losses was $25.5 million in the quarter and the allowance for credit losses reached $95.8 million at September 30, 2021, versus $67.8 million at December 31, 2020. The company also recorded $16.7 million of impairments on Agemo loans and $42.5 million of real estate impairments for the nine months. Omega committed up to $25 million of debtor-in-possession financing to Gulf Coast. The balance sheet remained sizable, with total assets of $9.78 billion, total debt of $5.27 billion, and total equity of $4.24 billion at September 30, 2021. Cash and cash equivalents were $102.7 million. The company issued $700 million of 3.25% senior notes due 2033 in March 2021, entered a new $1.45 billion revolving credit facility maturing April 30, 2025, and raised $272.4 million from common stock issuance in the nine months. Quarterly dividends of $0.67 per share were declared, including one payable November 15, 2021.
- 2021-Q2Aug 3, 2021
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2021
Omega Healthcare Investors, Inc. (filed under this name; the filing is its Form 10-Q for the quarter ended June 30, 2021) reported total revenues of $257.4 million for the three months ended June 30, 2021, up from $256.4 million a year earlier, and net income available to common stockholders of $84.5 million, or $0.36 per diluted share, versus $99.3 million, or $0.43, in the prior-year quarter. For the six months, net income available to common stockholders was $244.5 million ($1.04 per diluted share), compared with $189.2 million ($0.83) in 2020. The six-month results were lifted by a $104.5 million gain on assets sold and a $37.5 million impairment charge, and were reduced by a $30.1 million loss on debt extinguishment tied to the 2033 notes tender. Nareit FFO was $180.8 million for the quarter, down from $186.5 million, and $351.1 million for the six months, down from $367.5 million. The company reported that one operator, representing approximately 3% of revenue, told it in June 2021 that it would be unable to pay rent in the foreseeable future. Omega placed that operator on a cash basis and wrote off approximately $17.4 million of straight-line receivables in the quarter, and it has applied $2.5 million of the operator's security deposit against uncollected rent. Management said that many operators continue to face COVID-19 cost increases and occupancy declines, and that the adverse impact could be material, though it is not able to estimate the effect. Balance sheet activity during the first half included the issuance of $700 million of 3.250% Senior Notes due 2033 and a tender for $350 million of the 4.375% Senior Notes due 2023. The company also replaced its $1.25 billion revolving credit facility with a new $1.45 billion facility maturing April 30, 2025, and entered into a $1.0 billion at-the-market equity program. Total debt was $5.3 billion, approximately 55.9% of total capitalization, and cash and equivalents were $100.8 million at June 30, 2021. Subsequent events included acquisitions of Ohio and Maryland facilities and two U.K. facilities for $9.5 million.
- 2021-Q1May 4, 2021
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2021
Omega Healthcare Investors, Inc. ("Omega") reported first-quarter 2021 results in this Form 10-Q, with net income of $164.4 million, up from $92.3 million in the first quarter of 2020, and net income available to common stockholders of $160.0 million, or $0.69 per diluted share, versus $0.39 a year earlier. Total revenues were $273.8 million, compared with $253.0 million, driven mainly by $26.8 million of higher rental income from acquisitions, facilities placed in service and transitions. Results were helped by a $100.3 million net gain on the sale of 24 facilities for approximately $188.3 million in net cash proceeds, and were offset by $28.7 million of real estate impairments on four facilities and a $29.7 million loss on debt extinguishment tied to the March 2021 tender offer for 4.375% Senior Notes due 2023. Nareit FFO was $170.2 million, compared with $181.0 million in the prior-year period. The balance sheet grew, with total assets of $9.82 billion and total equity of $4.15 billion at March 31, 2021. The company issued $700 million of 3.250% Senior Notes due 2033 and reported acquisitions of $594.5 million in real estate during the quarter, including 24 facilities acquired from Healthpeak Properties. Cash and cash equivalents fell to $51.4 million. Subsequent to quarter end, on April 30, 2021, Omega closed a new four-year $1.45 billion senior unsecured credit facility and a new four-year $50 million OP term loan facility, replacing facilities that were scheduled to mature in May 2021 and May 2022. The filing continues to emphasize operator risk from COVID-19. Management states that it collected substantially all contractual rents in 2020 and the first quarter of 2021, but notes that four operators disclosed substantial doubt about their ability to continue as going concerns during the second half of 2020. Cases were reported at 212 of 949 operating facilities as of April 27, 2021, down from 614 facilities as of December 22, 2020. The company also faces a securities class action and derivative suits, and a Department of Justice civil investigation related to Lakeway Hospital, a 51%-owned unconsolidated joint venture. Management says it believes the claims are without merit and the outcome of the DOJ matter cannot yet be determined.
- 2020-Q3Nov 3, 2020
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2020
Omega Healthcare Investors, Inc. and its operating partnership, OHI Healthcare Properties Limited Partnership, filed a combined Form 10-Q for the quarter ended September 30, 2020. Omega owned approximately 97% of the Omega OP Units at quarter-end. Third-quarter results were heavily affected by non-cash charges: total operating revenues were $119.2 million versus $233.2 million a year earlier, and the company reported a net loss available to common stockholders of $91.3 million, or $(0.40) per share, compared with net income of $138.7 million in the prior-year quarter. The decline reflects a $142.3 million write-off of receivables and lease inducements after three operators (Genesis Healthcare, Agemo Holdings and another operator) were placed on a cash basis, a $28.1 million impairment on real estate, and a $32.1 million provision for credit losses that primarily relates to a $28.2 million reserve on Agemo term loans. Nareit FFO was $15.1 million for the quarter versus $163.1 million a year earlier, and $382.6 million for the nine months versus $464.4 million. Balance sheet and liquidity: total assets were $9.4 billion and debt was $5.2 billion, approximately 57.0% of total capitalization. Cash and cash equivalents were $35.9 million at quarter-end. Net cash from operating activities for the nine months was $510.9 million. The company maintained its quarterly dividend at $0.67 per share. After quarter-end, it issued $700 million of 3.375% Senior Notes due 2031 in October 2020 and used the net proceeds of about $680.5 million to repay the U.S. term loan and 2015 term loan and partially pay down the Omega OP term loan and revolver. The filing also highlights ongoing operator stress tied to COVID-19: roughly half of facilities reported at least one positive case as of October 22, 2020, and three operators have disclosed substantial doubt about their ability to continue as going concerns. The company is also defending a securities class action, which the Second Circuit reversed and remanded on August 3, 2020, and it is responding to a Department of Justice civil investigative demand related to the Lakeway Hospital held through MedEquities.
- 2020-Q2Aug 7, 2020
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2020
Omega Healthcare Investors, Inc. and its operating partnership, OHI Healthcare Properties Limited Partnership, filed a combined Form 10-Q for the quarter ended June 30, 2020. Total revenues were $256.4 million for the three months ended June 30, 2020, up from $225.3 million a year earlier, and $509.4 million for the six months, up from $449.0 million. Net income available to common stockholders was $99.3 million for the quarter ($0.43 diluted per share), compared with $73.1 million in the prior-year quarter. Nareit FFO was $186.5 million for the quarter versus $157.2 million a year earlier. Total assets were $9.69 billion and total debt was $5.3 billion, representing approximately 55.8% of total capitalization. The filing is dominated by COVID-19 disclosures. Management states the pandemic did not materially affect rental revenue in the first two quarters and that substantially all contractual rents were collected, but it says operators face significant cost increases and occupancy declines, and that the adverse impact could be material. Impairments on real estate were $12.0 million in the quarter and $15.6 million for the six months. The company also disclosed a pending restructuring of the Daybreak portfolio, where 28 facilities with a $147 million net book value may be sold for $100 million, with a potential impairment of approximately $47 million if the probability of sale increases. Liquidity measures included repaying a $300 million precautionary draw on the $1.25 billion revolving credit facility in June 2020, entering $400 million of forward starting swaps at an average rate of 0.8675%, and a $200 million stock repurchase authorization under which no shares were repurchased in the first half. Dividends were maintained at $0.67 per share for the first and second quarters. The filing also discloses a securities class action that the District Court dismissed in March 2019, and that the Second Circuit reversed on August 3, 2020, as well as a DOJ Civil Investigative Demand relating to MedEquities' Lakeway Hospital interest.
- 2020-Q1May 8, 2020
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2020
Omega Healthcare Investors, Inc. and its operating partnership, OHI Healthcare Properties Limited Partnership, filed a combined Form 10-Q for the quarter ended March 31, 2020. Total operating revenues were $253.0 million, up from $223.7 million, and net income available to common stockholders was $89.9 million, compared with $69.7 million a year earlier. Diluted earnings per share were $0.39 versus $0.34. Rental income rose to $221.5 million, driven by the MedEquities merger and the Encore Portfolio acquisition. Nareit FFO was $181.0 million compared with $144.1 million. The filing is dominated by COVID-19 disclosure. Management states the pandemic did not materially affect first-quarter rental revenue and that substantially all April contractual rents were collected, but it describes significant cost increases and occupancy declines at operators, and says the impact on the business could be material. Liquidity was reinforced by a $300 million precautionary draw on the $1.25 billion revolving credit facility, which raised the revolver balance to $516.8 million from $125.0 million. Cash and cash equivalents reached $348.0 million. The company also entered into $400 million of forward starting swaps, authorized a $200 million stock repurchase program (none executed through March 31, 2020), and suspended its dividend reinvestment plan. The quarterly dividend of $0.67 per share was maintained. Credit quality items to note include the adoption of ASU 2016-13, which added a $28.8 million allowance for expected credit losses at January 1, 2020, and a total allowance of $35.4 million at March 31, 2020. The filing also discloses a securities class action that was dismissed and is on appeal, a derivative action, and a DOJ Civil Investigative Demand related to the Lakeway Hospital, for which management cannot determine whether a loss is probable.
- 2019-Q3Nov 8, 2019
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2019
Omega Healthcare Investors, Inc. and its operating partnership, OHI Healthcare Properties Limited Partnership, filed a combined Form 10-Q for the quarter ended September 30, 2019. Total revenues were $233.2 million for the three months ended September 30, 2019, up $11.3 million from $221.9 million in the prior-year period, driven mainly by the MedEquities Merger and other acquisitions, partly offset by operators placed on a cash basis. Net income available to common stockholders was $138.7 million for the quarter, or $0.63 diluted per share, versus $56.6 million and $0.28 a year earlier. Nareit FFO was $163.1 million for the quarter compared to $160.6 million in the prior-year quarter. Total assets were $9.0 billion at September 30, 2019, with total debt of $4.7 billion, representing approximately 53.4% of total capitalization. The quarter included the May 17, 2019 completion of the MedEquities Merger, which added 33 facilities subject to operating leases and was funded with 7.5 million Omega shares and about $63.7 million of cash consideration. In September 2019 the company issued $500 million of 3.625% Senior Notes due 2029 and entered into a forward equity sales agreement for 7.5 million shares at an initial net price of $40.01 per share. Operator stress remained a theme: Daybreak Venture LLC paid only $750,000 of cash rent in the third quarter, and the company placed several operators on a cash basis, producing write-offs and an approximately $10.8 million revenue decrease in the quarter. Ciena Healthcare accounted for approximately 11% of total revenues for the three and nine months ended September 30, 2019. Subsequent to quarter end, the company completed the $735 million Encore Portfolio acquisition of 60 facilities on October 31, 2019, with approximately $346 million of cash and approximately $389 million of assumed HUD-guaranteed mortgage loans, and agreed on October 30, 2019 to buy a 49% joint venture interest in a U.K. portfolio for approximately $90 million. The Board declared a quarterly dividend of $0.67 per share, payable November 15, 2019, up from $0.66.
- 2019-Q2Aug 8, 2019
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2019
Omega Healthcare Investors, Inc. and its operating partnership, OHI Healthcare Properties Limited Partnership, filed a combined Form 10-Q for the quarter ended June 30, 2019. Total revenues for the three months ended June 30, 2019 were $225.3 million, up from $219.9 million a year earlier, and net income available to common stockholders was $73.1 million, or $0.35 per basic share, compared with $78.5 million in the prior-year quarter. For the six months, operating revenues were $449.0 million and net income available to common stockholders was $142.8 million. Nareit FFO was $157.2 million for the quarter versus $154.5 million a year earlier. The quarter was shaped by the May 17, 2019 merger with MedEquities Realty Trust, Inc., in which Omega issued approximately 7.5 million shares and paid about $63.7 million in cash. The company borrowed roughly $350 million under its revolving credit facility to fund the cash consideration and repay MedEquities' debt, and the filing describes the transaction at a fair value of consideration of approximately $346 million. Total assets were $9.10 billion at June 30, 2019, and the revolver balance rose to $500.0 million from $313.0 million at year-end 2018. Shares outstanding were 216,553,668 as of August 2, 2019. Credit and operator risk remained central. The company recorded a $7.7 million allowance on its Orianna distribution trust receivable in the first quarter and $5.7 million of net impairment charges in the second quarter, and it placed three operators on a cash basis, writing off about $6.7 million of receivables and lease inducements. Daybreak's rent expectations were reduced, and Ciena Healthcare accounted for approximately 11% of total revenues. Subsequent to quarter end, on July 26, 2019, the company agreed to buy 60 facilities for $735 million, subject to HUD consent.
- 2019-Q1May 9, 2019
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2019
Omega Healthcare Investors, Inc. ("Omega") and its operating partnership, OHI Healthcare Properties Limited Partnership ("Omega OP"), reported first-quarter 2019 total operating revenues of $223.7 million, up from $220.2 million in the first quarter of 2018. Net income available to common stockholders was $69.7 million, or $0.34 per basic and diluted share, compared with $84.2 million, or $0.42 per share, a year earlier. Nareit FFO was $144.1 million versus $147.4 million in the prior-year period. The decline in earnings was driven mainly by a $7.7 million impairment on direct financing leases tied to the Orianna Health Systems bankruptcy trust, a $3.8 million real estate tax expense from adopting the new lease standard, and a $2.9 million acquisition cost, partly offset by lower provisions for uncollectible accounts and real estate impairments. Balance sheet activity was driven by financing and portfolio changes. Total assets were $8.52 billion at March 31, 2019, and total debt was $4.5 billion, representing approximately 54.0% of total capitalization. The company issued 2.2 million shares under its equity shelf program for net proceeds of $76.5 million and raised $32.3 million through its dividend reinvestment plan. Operating cash flow was $110.1 million, compared with $52.9 million a year earlier. Common dividends of $0.66 per share were declared for both the first and second quarters of 2019. The filing also details a pending merger with MedEquities Realty Trust, Inc., with total consideration of approximately $600 million including assumed debt. Under the agreement, each MedEquities share converts into 0.235 of an Omega share plus $2.00 in cash. Omega is also a defendant in a securities class action, which was dismissed with prejudice on March 25, 2019 and is now on appeal, and in several lawsuits from MedEquities stockholders challenging the merger.
- 2018-Q3Nov 7, 2018
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2018
Omega Healthcare Investors, Inc. (Omega) and its operating partnership, OHI Healthcare Properties Limited Partnership (Omega OP), reported results for the quarter ended September 30, 2018. Total operating revenues for the three months were $221.9 million, up from $219.6 million a year earlier, while net income available to common stockholders was $56.6 million, compared with a loss of $(131.7) million in the third quarter of 2017, which included a $194.7 million impairment on direct financing leases tied to Orianna. For the nine months, net income available to common stockholders was $219.4 million, or $1.10 per diluted share. NAREIT FFO was $159.4 million for the quarter and $462.9 million for the nine months. The filing is dominated by the Orianna Health Systems (New Ark Investment Inc.) situation. Orianna filed for Chapter 11 in March 2018, and Omega terminated the restructuring support agreement on July 25, 2018. In the third quarter, Omega transitioned 22 facilities with a net carrying value of approximately $184.5 million to five existing operators, reducing its Orianna direct financing lease investment and related allowance by approximately 55%. The remaining Orianna exposure is a direct financing lease on 16 facilities with a net investment of $151.7 million after a $76.0 million allowance, plus other investments of about $40.2 million and a four-facility operating lease with a recorded investment of $36.8 million, which Orianna rejected after quarter end. Omega has recognized no direct financing lease income from Orianna since July 1, 2017. Balance sheet figures show total assets of $8.64 billion, total debt of $4.59 billion, and total equity of $3.79 billion at September 30, 2018. Other investments grew to $511.7 million from $276.3 million at year-end 2017, driven by new loans, including a $131.3 million secured term loan made on September 28, 2018. Cash and cash equivalents were $9.8 million. Management cites liquidity from operating cash flow, its credit facilities and expected mortgage payoffs as adequate for the next twelve months. The filing also discloses a securities class action filed in November 2017, which the company is contesting, and a related derivative action stayed pending the outcome of the class action.
- 2018-Q2Aug 8, 2018
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2018
Omega Healthcare Investors, Inc. (Omega), a self-administered REIT, and its operating partnership OHI Healthcare Properties Limited Partnership (Omega OP) filed a combined Form 10-Q for the quarter ended June 30, 2018. Total assets were $8.57 billion at June 30, 2018, down from $8.77 billion at December 31, 2017, and total equity was $3.85 billion. Operating revenues were $219.9 million for the second quarter, compared with $235.8 million a year earlier, and net income available to common stockholders was $78.5 million, or $0.39 per share. For the six months, net income available to common stockholders was $162.8 million, or $0.82 per share. NAREIT FFO was $155.5 million for the quarter, versus $150.9 million in the prior-year quarter. The company continued a strategic asset repositioning program, selling 14 facilities in the first quarter for about $74.7 million and 45 facilities plus one ancillary building in the second quarter for about $147.2 million. The largest operator issue is Orianna, which filed Chapter 11 in March 2018. Omega carries $172.2 million of allowance on Orianna's direct financing leases covering 38 facilities, and the filing notes that no direct financing lease income was recognized from Orianna over the prior twelve months. After the period end, on July 23 and July 25, 2018, Omega declared the Orianna DIP facility in default and terminated the restructuring support agreement. Omega also disclosed a securities class action filed in November 2017, which the company is contesting, and a motion to dismiss filed July 17, 2018. At June 30, 2018, debt was $4.4 billion, representing approximately 53.6% of total capitalization, and cash, cash equivalents and restricted cash were $13.5 million. Management stated that liquidity is adequate to meet obligations over the next twelve months. The quarterly common dividend was $0.66 per share, declared for payment in August 2018.
- 2018-Q1May 10, 2018
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2018
Omega Healthcare Investors, Inc. and its operating partnership, OHI Healthcare Properties Limited Partnership, filed a combined Form 10-Q for the quarter ended March 31, 2018. Total operating revenues were $220.2 million, down from $231.7 million in the prior-year quarter, primarily due to a $15.0 million decrease in direct financing lease income tied to operator Orianna Health Systems, which has not paid rent since July 1, 2017. Net income available to common stockholders was $84.2 million, or $0.42 per diluted share, versus $0.53 a year earlier, which included a $10.4 million contractual settlement gain. NAREIT FFO was $148.0 million compared with $181.0 million. Operating cash flow fell to $52.9 million from $112.5 million, reflecting higher contractual receivables, timing of interest payments and $28.4 million of lease inducement payments to one operator. The portfolio comprised 973 healthcare facilities in 41 states and the U.K. operated by 70 third-party operators, with total assets of $8.8 billion and debt of $4.6 billion, or approximately 54.5% of total capitalization. Orianna filed for Chapter 11 in March 2018; the company agreed to a restructuring support agreement and committed up to $30 million of DIP financing, and the filing states that a $172.2 million allowance has been recorded against the Orianna direct financing leases. Signature Healthcare, also more than 90 days past due on rent, reached a consensual out-of-court restructuring agreement on May 7, 2018. The company also faces a securities class action filed in late 2017, which the filing describes as at a very early stage.
- 2017-Q3Nov 7, 2017
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2017
Omega Healthcare Investors, Inc. and its operating partnership, OHI Healthcare Properties Limited Partnership ("Omega OP"), filed a combined Form 10-Q for the quarter ended September 30, 2017. For the three months ended September 30, 2017, total operating revenues were $219.6 million, down from $224.6 million a year earlier, and the company reported a net loss of $137.5 million, driven mainly by a $194.7 million impairment loss on direct financing leases tied to the Orianna portfolio. For the nine months, net income was $39.8 million, compared with $253.5 million in the prior-year period. Net loss available to common stockholders was $131.7 million for the quarter, or $(0.67) per share, versus $0.40 per share a year earlier. The filing identifies Orianna Health Systems (New Ark Investment Inc.) as the central credit concern. Orianna has not paid rent under its existing leases, and the company recorded a $171.9 million allowance for loss on direct financing leases covering 38 Southeast facilities. Management states that the current annual contractual rent of $46 million on Orianna facilities will likely be reduced to a range of $32 million to $38 million once the transition process is complete. Three operators were about 90 days or more past due on rent at quarter-end, and one of them, Signature Healthcare, is described as pursuing an out-of-court restructuring. Ciena Healthcare accounted for 11% of total revenues in the quarter. On the balance sheet, total assets were $8.89 billion and total debt was $4.64 billion, which management states represents approximately 54.1% of total capitalization. Management states liquidity is adequate for the next twelve months. Quarterly common dividends declared were $0.64 per share, with $0.65 declared for the period ending October 31, 2017. NAREIT FFO was a deficit of $(46.8) million for the quarter, compared with $162.6 million a year earlier, and $285.1 million for the nine months, compared with $488.5 million.
- 2017-Q1-AAug 9, 2017
Omega Healthcare Investors Quarterly Report (Amendment) for Q1 Ended Mar 31, 2017
Omega Healthcare Investors, Inc. (with co-registrants OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership) filed this Form 10-Q/A for the quarter ended March 31, 2017. The amendment was filed to add the consolidated financial statements of the Guarantors (OHI Holdco and Omega OP) under Rule 3-10 of Regulation S-X, after subsidiary guarantors other than those two were released. The Parent's consolidated financial statements are unchanged from the original filing. Management concluded that disclosure controls were not effective as of March 31, 2017 because separate guarantor financial statements were not filed with the original report. For the first quarter of 2017, total operating revenues were $231.7 million, up from $212.9 million, and net income available to common stockholders was $104.4 million, or $0.53 per diluted share, compared with $0.29 in the prior-year period. Impairment losses fell to $7.6 million from $34.6 million, and the filing reports a one-time $10.4 million contractual settlement. Net cash provided by operating activities was $113.9 million. The filing reports NAREIT FFO of $181.0 million versus $153.6 million a year earlier. Dividends declared were $0.62 per share, and the Board declared $0.63 for the second quarter. The balance sheet at March 31, 2017 showed total assets of $8.8 billion, total debt of $4.3 billion, and total equity of $4.2 billion. Subsequent events include a new $1.8 billion senior unsecured credit facility entered May 25, 2017, issuance of $700 million of senior notes in April 2017 (including $550 million of 4.75% notes due 2028 and $150 million of additional 4.50% notes due 2025), and redemption of the $400 million 5.875% notes due 2024.
- 2017-Q2Aug 9, 2017
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2017
Omega Healthcare Investors, Inc. (Omega) and its subsidiaries OHI Healthcare Properties Holdco, Inc. and OHI Healthcare Properties Limited Partnership filed a combined Form 10-Q for the quarter ended June 30, 2017. Omega is a self-administered REIT operating as an UPREIT, with a portfolio of 999 healthcare facilities in 42 states and the U.K. operated by 77 third-party operators, and an investment of approximately $9.0 billion net of impairments and reserves. At June 30, 2017, total assets were $8.9 billion, total equity $4.2 billion and debt $4.4 billion, representing approximately 51.5% of total capitalization. Six-month revenues were $467.5 million, up from $441.7 million, and net income available to common stockholders was $169.7 million, or $0.86 per diluted share, compared with $0.86 in the prior-year period on a diluted basis. Three-month NAREIT FFO was $150.9 million versus $172.3 million a year earlier. Six-month results were shaped by refinancing activity. The company issued $550 million of 4.75% senior notes due 2028 and $150 million of additional 4.50% notes due 2025, redeemed its $400 million 5.875% notes, and entered a new $1.8 billion unsecured credit facility on May 25, 2017. Refinancing costs of $22.0 million were recorded in the second quarter, and a $10.4 million contractual settlement benefited the first half. Operating cash flow was $265.6 million for the six months, down from $286.9 million, which the filing attributes primarily to an increase in contractual receivables from two operators. The filing flags operator credit risk. Two of the top 10 operators were approximately 90 days past due on rent at June 30, 2017, and the company is working through restructuring and asset sales with them. Management also discusses pending federal healthcare reform legislation, Medicare SNF payment changes, and Medicaid funding proposals as uncertainties for operators. Dividends declared were $0.63 per share for the second quarter, and a $0.64 per share dividend was declared on July 13, 2017.
- 2017-Q1May 5, 2017
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2017
Omega Healthcare Investors, Inc. reported first-quarter 2017 total operating revenues of $231.7 million, up from $212.9 million in the prior-year quarter, with net income available to common stockholders of $104.4 million, or $0.53 per diluted share, compared with $55.6 million, or $0.29 per diluted share, a year earlier. The increase was driven primarily by $15.8 million of rental income from acquisitions and lease amendments made throughout 2016 and a $3.5 million increase in other investment income. Operating expenses fell to $92.5 million from $116.3 million, mainly because impairment losses dropped by $26.9 million, and the quarter included a one-time $10.4 million contractual settlement. NAREIT FFO was $181.0 million compared with $153.6 million in the prior-year period. Balance sheet activity centered on debt reduction and capital raising. Total assets were $8.84 billion at March 31, 2017, and total debt was $4.30 billion, which the filing states represents approximately 50.5% of total capitalization. The revolving line of credit was reduced to $123.0 million from $190.0 million. Cash and cash equivalents fell to $40.3 million from $93.7 million at year-end 2016. The company sold 15 facilities for approximately $45.8 million in net proceeds, and it declared a quarterly common dividend of $0.63 per share on April 13, 2017, up $0.01 from the prior quarter. Subsequent to quarter end, on April 4, 2017, the company issued $550 million of 4.75% Senior Notes due 2028 and an additional $150 million of 4.50% Senior Notes due 2025, with net proceeds of approximately $690.7 million. These proceeds were used to redeem the $400 million 5.875% Senior Notes due 2024, prepay the $200 million Tranche A-2 Term Loan, and repay revolver borrowings. The company expects to record approximately $16.5 million in redemption-related costs and write-offs in the second quarter of 2017.
- 2016-Q3Nov 8, 2016
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2016
Omega Healthcare Investors, Inc. reported third-quarter 2016 results in its Form 10-Q for the quarter ended September 30, 2016. Total operating revenues were $224.6 million for the three months, up $22.7 million from the prior-year period, and $666.3 million for the nine months, up $133.2 million. Net income available to common stockholders was $78.5 million for the quarter ($0.40 per diluted share), compared with $79.4 million a year earlier. Impairment losses on real estate rose to $17.3 million in the quarter from $1.7 million, reflecting the company's plan to exit certain non-strategic facilities, mostly acquired in the Aviv Merger. Nine-month net income available to common stockholders was $242.2 million, or $1.26 per diluted share, versus $163.9 million, or $0.97, in 2015. The balance sheet grew substantially. Total assets were $8.98 billion at September 30, 2016, compared with $8.02 billion at December 31, 2015. Total debt was $4.4 billion, which the filing states represents approximately 51.5% of total capitalization. Key financing included a $700 million 4.375% Senior Notes offering due 2023, completed in July 2016, and the purchase of a $180.0 million mortgage term loan that eliminated that debt from the consolidated balance sheet. Cash and cash equivalents were $32.6 million. Operating cash flow was $457.2 million for the nine months. The company declared a quarterly common dividend of $0.61 per share in October 2016, up $0.01 from the prior quarter. Management stated that its liquidity is adequate to fund operations, debt service, dividends and investments over the next twelve months. The portfolio comprised 1,014 healthcare facilities in 42 states and the United Kingdom, operated by 81third-party operators, with about 99% of real estate investments in long-term care facilities. The filing also details the Medicare and Medicaid regulatory changes affecting its operators, including a CMS final rule on SNF conditions of participation.
- 2016-Q2Aug 5, 2016
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2016
Omega Healthcare Investors, Inc. reported operating revenues of $228.8 million for the quarter ended June 30, 2016, up from $197.7 million a year earlier, and $441.7 million for the six months, up from $331.1 million. Net income available to common stockholders was $108.1 million ($0.57 per diluted share) for the quarter, compared with $41.4 million ($0.22) in the prior-year quarter. The six-month results were affected by $41.5 million of real estate impairments and $7.3 million of acquisition and merger costs, versus $51.9 million of merger costs in the prior-year period. NAREIT FFO was $172.3 million for the quarter and $325.9 million for the six months, compared with $100.7 million and $180.4 million a year earlier. At June 30, 2016, total assets were $8.61 billion, total equity was $4.10 billion, and debt was $4.2 billion, which the filing states represents approximately 50.4% of total capitalization. The portfolio comprised 986 healthcare facilities in 42 states and the United Kingdom, operated by 84 third-party operators, with 799 SNFs and 97 ALFs. The company acquired 37 SNFs and 17 ALFs during 2016 for $653.3 million in total investment, and sold 11 facilities in the second quarter for about $41.4 million in net proceeds. Subsequent to quarter-end, the company issued $700 million of 4.375% Senior Notes due 2023 on July 12, 2016, and on July 25, 2016 purchased the $180 million mortgage term loan secured by 28 facilities, paying $180 million plus a 1% prepayment fee. The Board declared a quarterly common dividend of $0.60 per share on July 14, 2016, up from $0.58. The filing also adds a risk factor on the U.K. vote to leave the European Union, which affects the company's U.K. investments.
- 2016-Q1May 6, 2016
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2016
Omega Healthcare Investors, Inc. reported operating revenues of $212.9 million for the three months ended March 31, 2016, up from $133.4 million in the prior-year period, driven mainly by $57.8 million of rental income from the Aviv Merger and $12.3 million from other acquisitions and lease amendments. Net income was $58.2 million, and net income available to common stockholders was $55.6 million, or $0.30 per basic share (diluted net income per share was $0.29). Results were weighed down by $34.6 million of impairments on 14 facilities being exited, which the company reclassified to assets held for sale, along with depreciation and amortization that rose to $62.4 million from $30.6 million. The balance sheet expanded considerably in the quarter. Total assets grew to $8.62 billion from $8.02 billion at year-end 2015, largely reflecting $416.1 million of real estate acquisitions and a $113.8 million deposit for the UK care homes acquired on April 1, 2016. Revolving line of credit borrowings rose to $530.0 million from $230.0 million, and the company added a $350 million Tranche A-3 term loan under its amended credit facilities. Total debt was reported at $4.2 billion, representing approximately 51.0% of total capitalization. Operating cash flow was $127.2 million, and the company paid $107.5 million in dividends during the quarter, while declaring a common dividend of $0.58 per share for the second quarter. The portfolio at March 31, 2016 consisted of 985 healthcare facilities in 42 states and the United Kingdom, operated by 83 third-party operators, with gross investment of approximately $8.4 billion. Approximately 99% of real estate investments related to long-term care facilities, and no single operator generated more than 10% of total revenues. NAREIT FFO was $153.6 million for the quarter, compared with $79.6 million a year earlier.
- 2015-Q3Nov 6, 2015
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2015
Omega Healthcare Investors, Inc. reported its 10-Q for the quarter ended September 30, 2015. The company operates one reportable segment of healthcare-related real estate in the United States and United Kingdom, focused on skilled nursing facilities and triple-net leases. Following the April 1, 2015 Aviv Merger, total assets rose to $8.59 billion from $3.92 billion at December 31, 2014, and total equity reached $4.06 billion. Total operating revenues for the three months ended September 30, 2015 were $202.0 million, up from $130.7 million, and net income available to common stockholders was $79.4 million, or $0.43 per diluted share, compared with $61.7 million in the prior-year quarter. NAREIT FFO for the quarter was $147.5 million versus $93.9 million a year earlier. The quarter included $216.0 million of new investments across six transactions, and the portfolio comprised 947 healthcare facilities operated by 83 third-party operators, with gross investment of approximately $8.0 billion. Acquisition and merger related costs were $55.5 million for the nine months, driven largely by the Aviv Merger. Debt totaled $4.2 billion, representing approximately 51.1% of total capitalization. Management stated that liquidity is adequate to finance operations, debt service and investments over the next twelve months. Subsequent to quarter end, the Board declared a quarterly common dividend of $0.56 per share, and the company redeemed its 6.75% Senior Notes due 2022 in October 2015 after depositing approximately $615.0 million with the trustee. The company also established a $500 million equity shelf program, although no shares had been issued under it as of September 30, 2015.
- 2015-Q2Aug 5, 2015
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2015
Omega Healthcare Investors, Inc. reported results for the quarter ended June 30, 2015, a period dominated by its April 1, 2015 merger with Aviv REIT, Inc., which added 342 facilities and was valued at approximately $3.8 billion. Total operating revenues for the three months ended June 30, 2015 were $197.7 million, up from $121.8 million a year earlier, and net income available to common stockholders was $41.4 million, or $0.22 diluted per share, compared with $46.8 million ($0.37 per share) in the prior-year quarter. Total operating expenses rose to $123.5 million, driven mainly by $47.1 million of acquisition costs and $59.2 million of depreciation and amortization. Total assets grew to $7.81 billion from $3.92 billion at December 31, 2014, and total equity reached $4.08 billion. Balance sheet growth was funded largely by an approximately $440 million common stock offering in February 2015, a $700 million 4.50% Senior Notes issuance due 2027, and assumed Aviv debt, with the company repaying about $1.2 billion of Aviv debt at closing. Other activity included a May 1, 2015 purchase/leaseback of 23 United Kingdom care homes, a $112 million Manhattan real estate acquisition announced as a subsequent event, and a quarterly common dividend declared at $0.55 per share for payment in August 2015. Management reported NAREIT FFO of $100.7 million for the quarter, compared with $79.7 million a year earlier, and stated that liquidity is adequate for the next twelve months. Investors should note that the quarter's GAAP earnings per share declined despite the larger asset base, reflecting merger-related acquisition costs, higher interest expense on increased borrowings, and impairments of $6.9 million on a Tennessee facility. The company also disclosed a preliminary deferred tax liability of approximately $16 million tied to the UK acquisition and a material internal control integration effort covering Aviv's operations.
- 2015-Q1May 8, 2015
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2015
Omega Healthcare Investors, Inc. reported first-quarter 2015 total operating revenues of $133.4 million, up from $121.0 million in the prior-year quarter, and net income available to common stockholders of $43.1 million, or $0.32 per diluted share, compared with $55.8 million, or $0.45 per diluted share, a year earlier. The company's real estate portfolio at March 31, 2015 comprised 569 healthcare facilities in 38 states operated by 50 third-party operators, with a gross investment of approximately $4.4 billion. Net income declined mainly because of a $6.0 million impairment on three Florida SNFs, $4.8 million of acquisition costs tied to the Aviv merger, and $9.4 million of net interest refinancing costs, including the redemption of the 7.5% Senior Notes due 2020. The balance sheet changed significantly during the quarter. Cash and cash equivalents rose to $700.1 million from $4.5 million at December 31, 2014, reflecting $440 million of net proceeds from a 10.925 million share common stock offering and $683 million of net proceeds from $700 million of 4.50% Senior Notes due 2027. Total assets reached $4.6 billion and total liabilities $2.8 billion, with stockholders' equity of $1.77 billion. The company also repaid 21 HUD mortgage loans for approximately $154.3 million on March 31, 2015. The filing is dominated by subsequent events. On April 1, 2015, Omega completed its merger with Aviv REIT, acquiring 348 properties in 30 states operated by 37 third-party operators and issuing approximately 43.7 million shares, and it completed an UPREIT conversion. The company also amended its bank credit facilities, raising the revolving commitment to $1.25 billion and adding a $200 million acquisition term loan and a $100 million Omega OP term loan. Quarterly dividend declarations rose to $0.54 per share, and a $179 million purchase/leaseback of 23 United Kingdom care homes closed on May 1, 2015, introducing foreign currency exposure.
- 2014-Q3Nov 7, 2014
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2014
Omega Healthcare Investors, Inc. ("Omega") reported its third-quarter 2014 results in this Form 10-Q, with a core business of financing and capital to the long-term healthcare industry, focused on skilled nursing facilities (SNFs) in the United States under triple-net leases and fixed-rate mortgage loans. For the three months ended September 30, 2014, total operating revenues were $130.7 million, up $27.4 million from $103.3 million in the prior-year period, and net income available to common stockholders was $61.7 million, or $0.48 per diluted share, versus $0.32 a year earlier. For the nine months, revenues were $373.5 million and net income was $164.4 million, or $1.30 per diluted share. Funds from operations available to common stockholders were $93.9 million for the quarter and $258.0 million for the nine months, compared with $70.3 million and $222.9 million in the prior-year periods. At September 30, 2014, total assets were $3.86 billion, stockholders' equity was $1.41 billion, and debt was $2.3 billion. The company issued $250 million of 4.50% Senior Notes due 2025 in September 2014 and $400 million of 4.95% Senior Notes due 2024 in March 2014, and entered into a new $1.2 billion unsecured credit facility in June 2014. The portfolio comprised 564 healthcare facilities in 38 states operated by 50 third-party operators. New Ark Investment (13% of total investments) and Genesis HealthCare (11% of revenues) were the largest concentrations. Management stated that liquidity was adequate for the next twelve months. A significant subsequent event is the October 31, 2014 agreement to merge with Aviv REIT, Inc., in which each Aviv common share would convert into 0.90 of a share of Omega common stock. The filing notes that completion is subject to stockholder approvals, an effective registration statement, and other conditions, and that Aviv investors are expected to own approximately 30% of the combined company. The board also declared a quarterly common dividend of $0.52 per share on October 16, 2014, up $0.01 from the prior quarter.
- 2014-Q2Aug 6, 2014
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2014
Omega Healthcare Investors, Inc. reported operating revenues of $121.8 million for the three months ended June 30, 2014, up from $102.5 million a year earlier, and $242.8 million for the six months, up from $204.3 million. Net income available to common stockholders was $46.8 million for the quarter ($0.37 per diluted share) and $102.6 million for the six months ($0.81 per diluted share). Growth was driven mainly by $28.2 million of direct financing lease revenue from the New Ark purchase/leaseback, higher mortgage interest income from a $112.5 million first mortgage loan, and added rental income from acquisitions and lease amendments. Funds from operations available to common stockholders was $79.7 million for the quarter, compared with $82.4 million in the prior-year quarter. The balance sheet expanded sharply during the first half of 2014. Mortgage notes receivable rose to $652.3 million from $241.5 million at December 31, 2013, and total assets reached $3.89 billion. Total debt was about $2.4 billion, representing approximately 63.0% of total capitalization. In June 2014 the company entered into a new $1.2 billion unsecured credit facility, consisting of a $1 billion revolver and a $200 million term loan, and sold $400 million of 4.95% Senior Notes due 2024 in March. The company also declared a quarterly common dividend of $0.51 per share, up $0.01 from the prior quarter. Operating and collection risks were noted, including a $2.7 million provision for uncollectible receivables and a $1.6 million impairment charge in the quarter. The filing states that no mortgages were in default or in foreclosure as of June 30, 2014, and that the company was in compliance with all debt covenants. Operator concentration remained significant: New Ark represented 13% of total investments and 12% of quarterly revenues, and Genesis HealthCare represented 11% of quarterly revenues.
- 2014-Q1May 7, 2014
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2014
Omega Healthcare Investors, Inc. reported operating revenues of $121.0 million for the three months ended March 31, 2014, up $19.2 million from $101.8 million in the same period of 2013, driven mainly by about $14.1 million of direct financing lease revenue tied to the Ark Holding Company purchase/leaseback completed in November 2013, a $2.0 million increase in mortgage interest income from a new mortgage, and an additional $2.8 million of rental income from acquisitions and lease amendments. Net income available to common stockholders was $55.8 million, or $0.45 per diluted share, versus $38.1 million, or $0.34 per diluted share, a year earlier. Funds from operations available to common stockholders was $84.4 million, compared to $70.1 million in the prior-year period. The balance sheet expanded during the quarter. Total assets rose to $3.58 billion at March 31, 2014 from $3.46 billion at December 31, 2013, and total debt was $2.1 billion, representing approximately 60.7% of total capitalization. The company placed a $112.5 million first mortgage loan with an existing operator, bearing an initial 9.5% interest rate, and issued $400 million of 4.95% Senior Notes due 2024 in March 2014, using the proceeds to repay the $200 million 2013 Term Loan Facility and part of its revolving credit facility. The revolver had no outstanding balance at quarter end, leaving $500 million of availability. Cash dividends of $0.49 per share were paid in the quarter, and the board declared $0.50 per share for payment in May 2014. Concentration and operator risk remain notable. The portfolio comprised 548 healthcare facilities in 38 states operated by 49 third-party operators, with gross investment of approximately $4.0 billion. New Ark Investment, Inc. accounted for 13% of total investments and about 12% of Q1 revenues, and Genesis HealthCare accounted for 11% of revenues. Florida represented 16% of investments. The company also disclosed an expected impairment of $1.0 million to $1.5 million in the second quarter of 2014 related to an Indiana MR/DD facility that was effectively closed in May 2014.
- 2013-Q3Nov 7, 2013
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2013
Omega Healthcare Investors, Inc. reported third-quarter 2013 results in this Form 10-Q, with total operating revenues of $103.3 million for the three months ended September 30, 2013, up from $87.1 million a year earlier, and net income available to common stockholders of $38.1 million, or $0.32 per diluted share, compared with $30.1 million ($0.27 per diluted share) in the prior-year quarter. For the nine months, revenues were $307.6 million and net income was $125.3 million ($1.08 per diluted share). The filing attributes the revenue increase mainly to rental income from 2012 acquisitions and a lease amendment and extension, and notes a $2.3 million provision for uncollectible straight-line rent tied to the transition of 11 Arkansas facilities to a new operator. Total assets were $3.01 billion, stockholders' equity was $1.19 billion, and debt was $1.7 billion, representing approximately 58.8% of total capitalization. Dividends declared and paid were $0.47 per share in the quarter, and the Board declared a $0.48 per share dividend on October 15, 2013. The portfolio at September 30, 2013 comprised 480 healthcare facilities in 34 states operated by 48third-party operators, with a gross investment of approximately $3.3 billion and about 99% of real estate investments in long-term care facilities. Concentration is notable: Genesis Healthcare accounted for 11% of total investments and CommuniCare Health Services for 10%, and Florida (18%), Ohio (11%) and Indiana (10%) were the top states. Subsequent events include an October 2013 underwritten offering of 2,875,000 shares at $30 per share, with net proceeds of approximately $84.5 million, and about $33 million of October acquisitions in Florida and Indiana. Liquidity appears comfortable on the filing's own terms: cash and equivalents rose to $67.8 million, operating cash flow for the nine months was $200.1 million, and $500 million was available under the revolving credit facility at quarter-end. The company also committed in September 2013 to a $525 million sale/leaseback with Ark Holding, subject to closing conditions, and funded a $15.0 million deposit toward it.
- 2013-Q2Aug 5, 2013
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2013
Omega Healthcare Investors, Inc. reported results for the three and six months ended June 30, 2013 in this Form 10-Q, with unaudited financial statements. Total operating revenues were $102.5 million for the quarter, up $18.7 million from the prior-year period, driven mainly by rental income from acquisitions made throughout 2012 and a lease amendment/extension. Net income available to common stockholders was $49.1 million, or $0.42 per diluted share, versus $30.6 million ($0.29) a year earlier. Funds from operations was $82.4 million for the quarter and $152.5 million for the six months, compared with $55.8 million and $104.0 million in the prior-year periods. The quarter also included an $11.1 million interest refinancing gain tied to retiring 11 HUD mortgages in May 2013. The balance sheet shows total assets of $2.98 billion and total liabilities of $1.84 billion at June 30, 2013, with stockholders' equity of $1.14 billion. Total debt was $1.7 billion, about 60.0% of total capitalization. Common shares outstanding rose to 117.2 million from 112.4 million at year-end 2012, largely through the 2013 equity shelf program and dividend reinvestment plan. The company's portfolio at June 30, 2013 comprised 480 healthcare facilities in 34 states operated by 47 third-party operators, with gross investment of about $3.3 billion. Florida (18%) was the largest state concentration, and Genesis Healthcare (11%) and CommuniCare Health Services (10%) were the only operators above 10% of total investment. The Board declared a common dividend of $0.47 per share on July 16, 2013, up $0.01 from the prior quarter. The company stated it was in compliance with its borrowing covenants and that its liquidity was adequate for the next twelve months. The filing also describes ongoing healthcare reform, Medicare and Medicaid reimbursement changes, and sequestration as factors that could affect its operators.
- 2013-Q1May 9, 2013
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2013
Omega Healthcare Investors, Inc. reported operating revenues of $101.8 million for the three months ended March 31, 2013, up $17.2 million from $84.5 million in the prior-year period, driven mainly by rental income from acquisitions made throughout 2012. Net income available to common stockholders was $38.1 million, or $0.34 per diluted share, compared with $26.1 million, or $0.25 per diluted share, a year earlier. Funds from operations available to common stockholders was $70.1 million, versus $48.2 million in the prior-year quarter. Operating cash flow was $57.6 million, and the company paid dividends of $0.45 per share in the quarter. At March 31, 2013, total assets were $3.0 billion, stockholders' equity was $1.1 billion, and debt was $1.8 billion, which the filing states represents approximately 61.5% of total capitalization. The company sold 1.5 million shares under its new $250 million equity shelf program at an average price of $29.41, and terminated its $245 million 2012 equity shelf program after issuing about 1.0 million shares under it. Cash and cash equivalents rose to $25.6 million. The portfolio comprised 479 healthcare facilities in 34 states operated by 46 third-party operators, with Genesis Healthcare (11%) and CommuniCare Health Services (10%) the only operators above 10% of total investment. Subsequent events include a $24.7 million mezzanine loan at 12% per annum maturing in December 2017, and plans to retire the HUD Berkadia mortgages using approximately $51.1 million drawn from the 2012 Credit Facility. On April 16, 2013, the Board declared a quarterly common dividend of $0.46 per share, payable May 15, 2013.
- 2012-Q3Nov 7, 2012
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2012
Omega Healthcare Investors, Inc. reported total operating revenues of $87.1 million for the three months ended September 30, 2012, up from $72.8 million a year earlier, and net income of $30.1 million, or $0.27 diluted per share, versus $21.4 million and $0.21 in the prior-year quarter. For the nine months ended September 30, 2012, total operating revenues were $255.4 million and net income was $86.8 million, or $0.81 diluted per share. The filing attributes the revenue growth mainly to new acquisitions in late 2011 and in the second and third quarters of 2012, including 27 facilities in Indiana purchased from Health and Hospital Corporation on August 31, 2012 for approximately $203 million in cash plus an assumed lease liability of approximately $13.9 million. Balance sheet growth was funded largely through debt and equity. Total assets rose to $2.76 billion at September 30, 2012 from $2.56 billion at December 31, 2011, and total liabilities rose to $1.74 billion. The company issued $400 million of 5.875% Senior Notes due 2024, used the proceeds to retire the $175 million 7% 2016 Notes, and reduced its revolving line of credit to $102.0 million from $272.5 million, leaving $373.0 million of availability. It also sold 2.6 million shares under a $245 million equity shelf program and issued 4.8 million shares through its dividend reinvestment plan. Common dividends declared rose to $0.44 per share for the fourth quarter of 2012, up from $0.42. The filing states that 403 SNFs, 14 assisted living facilities and 11 specialty facilities made up the leased portfolio, with 99% of real estate investments tied to long-term care facilities. CommuniCare accounted for 11% of total investments and 13% of revenues for the quarter, and Sun Healthcare for 10% of quarterly revenues. Management stated that the company was in compliance with all covenants under its credit facility and that none of its mortgages were in default or in foreclosure.
- 2012-Q2Aug 7, 2012
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2012
Omega Healthcare Investors, Inc. reported second-quarter 2012 results in this Form 10-Q, with total operating revenues of $83.8 million for the three months ended June 30, 2012, up from $72.6 million a year earlier, and net income of $30.6 million, or $0.29 per diluted share, compared with $17.8 million, or $0.17 per share. For the six months, revenues were $168.3 million and net income was $56.7 million, or $0.54 per diluted share. Funds from operations available to common stockholders was $55.8 million for the quarter and $104.0 million for the six months, compared with $42.6 million and $81.7 million in the prior-year periods. Management attributed the revenue growth mainly to fourth-quarter 2011 acquisitions, new mortgage loans, and lease amendments, and noted that the prior-year quarter included a $4.1 million provision for uncollectible accounts. The balance sheet shows total assets of $2.55 billion and total liabilities of $1.62 billion at June 30, 2012, with stockholders' equity of $935.7 million. Long-term debt was $1.49 billion, which the filing states represents approximately 61.4% of total capitalization. During the first half, the company issued $400 million of 5.875% Senior Notes due 2024, tendered for and redeemed its $175 million 7% Senior Notes due 2016, and terminated its $140 million equity shelf program, while entering into a new $245 million equity shelf program. Operationally, the portfolio comprised 437 healthcare facilities in 34 states operated by 47 third-party operators, and CommuniCare Health Services was the largest operator at 12% of total investment. The company also declared a quarterly common dividend of $0.42 per share, and management stated that its liquidity is adequate for the next twelve months.
- 2011-Q3-AMay 24, 2012
Omega Healthcare Investors Quarterly Report (Amendment) for Q3 Ended Sep 30, 2011
Omega Healthcare Investors, Inc., a Maryland corporation headquartered in Hunt Valley, MD, filed this Amendment No. 1 on Form 10-Q/A to its Quarterly Report for the period ended September 30, 2011. The amendment was filed solely to re-file Exhibit 10.1, the Credit Agreement dated as of August 16, 2011, among the Company, certain subsidiary guarantors, the lenders named therein, and Bank of America, N.A. The re-filed exhibit includes portions that had previously been redacted under a request for confidential treatment, and it supersedes the originally filed exhibit in its entirety. The amendment states that no other changes have been made to the Form 10-Q. It speaks as of the original filing date, does not reflect later events, and does not modify or update any disclosures in the original report. The Company also included new certifications from its chief executive officer and chief financial officer under Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Exhibits 31.1 and 31.2. The registrant identified itself as a large accelerated filer and not a shell company, and it reported that it had submitted and posted its Interactive Data Files. As of October 28, 2011, it had 103,166,383 shares of common stock, $.10 par value, outstanding.
- 2012-Q1May 8, 2012
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2012
Omega Healthcare Investors, Inc. reported total operating revenues of $84.5 million for the three months ended March 31, 2012, up from $70.5 million in the prior-year period, driven mainly by rental income of $76.0 million and mortgage interest income of $7.3 million. Net income was $26.1 million, or $0.25 per diluted share, compared with a net loss available to common stockholders of $11.1 million in the first quarter of 2011, which included a $25.0 million impairment loss on Connecticut properties. Funds from operations available to common stockholders was $48.2 million, compared with $39.1 million a year earlier. Cash flow from operations was $49.5 million, and the Board declared a quarterly common dividend of $0.42 per share for payment on May 15, 2012. The company's portfolio at March 31, 2012 consisted of 435 healthcare facilities in 33 states operated by 47 third-party operators, with a gross investment of approximately $2.8 billion and 99% of real estate investments in long-term care facilities. CommuniCare Health Services represented 12% of total investment and 13% of revenues in the quarter, and Sun Healthcare represented 10% of revenues. Total debt was $1.5 billion, representing approximately 63.4% of total capitalization. During the quarter, the company issued $400 million of 5.875% Senior Notes due 2024 and tendered for $168.9 million of its 7% Senior Notes due 2016, redeeming the remaining $6.1 million. The redemption produced approximately $7.1 million of related costs and write-offs. The $27.0 million outstanding under its $475 million unsecured revolving credit facility left $448.0 million of availability. The company stated it was in compliance with all covenants and believes its liquidity is adequate for the next twelve months.
- 2011-Q3Nov 7, 2011
Omega Healthcare Investors Quarterly Report for Q3 Ended Sep 30, 2011
Omega Healthcare Investors, Inc. reported third-quarter 2011 results in this Form 10-Q. Total operating revenues were $72.8 million for the quarter, up $3.1 million from the prior year period, and net income was $21.4 million, or $0.21 per diluted share. For the nine months ended September 30, 2011, revenues were $215.9 million and net income was $33.3 million, or $0.28 per diluted share, compared with $0.50 a year earlier. The nine-month results include a $25.0 million impairment on real estate properties, primarily related to the Connecticut facilities, and a $4.1 million provision for uncollectible accounts. Funds from operations available to common stockholders was $44.5 million for the quarter, compared with $42.5 million a year earlier. The balance sheet shows total assets of $2.23 billion and total stockholders' equity of $897.8 million at September 30, 2011. Debt stood at $1.2 billion, representing approximately 57.6% of total capitalization. During the period the company redeemed its 8.375% Series D Preferred Stock and entered a new $475 million unsecured revolving credit facility, with $45.0 million drawn at quarter end. The Board also authorized a $100 million stock repurchase program, under which 183,310 shares were bought at an average price of $15.96 on September 30. The quarterly common dividend was raised to $0.40 per share. The filing notes significant regulatory pressure on operators, including a reduction of $3.87 billion, or 11.1%, in aggregate Medicare reimbursement to skilled nursing facilities for fiscal year 2012. Management believes operator coverage ratios remain adequate to absorb moderate rate reductions. Subsequent to quarter end, on October 31, 2011, the company completed approximately $69 million of new investments with Persimmon Ventures, LLC, a new operator.
- 2011-Q2Aug 8, 2011
Omega Healthcare Investors Quarterly Report for Q2 Ended Jun 30, 2011
Omega Healthcare Investors, Inc. reported total operating revenues of $72.6 million for the three months ended June 30, 2011, up from $58.8 million in the prior-year period, driven mainly by rental income from the June 2010 CapitalSource acquisitions. Net income for the quarter was $17.8 million, and net income available to common stockholders was $17.8 million, or $0.17 per diluted share. For the six months ended June 30, 2011, net income available to common stockholders was $6.7 million, or $0.07 per diluted share, after a $24.4 million impairment on Connecticut skilled nursing facilities recorded in the first quarter and a $4.1 million provision for uncollectible accounts recorded in the second quarter. Funds from operations available to common stockholders was $42.6 million for the quarter, compared with $29.7 million a year earlier. The balance sheet shows total assets of $2.24 billion and total stockholders' equity of $902.1 million at June 30, 2011. Total debt was $1.23 billion, and the company stated this represented approximately 57.6% of total capitalization. In the first quarter, the company redeemed its 8.375% Series D Preferred Stock for $108.6 million, funded in part by about $103 million of borrowings under its $320 million revolving credit facility, of which $53.0 million was outstanding at quarter end. The company also declared a common dividend of $0.40 per share on July 14, 2011, up from $0.38 in the prior quarter, and said it believes liquidity is adequate for the next twelve months. The filing describes a portfolio of 400 healthcare facilities in 35 states operated by 50 third-party operators, with an gross investment of approximately $2.5 billion, and 99% of real estate investments in long-term care facilities. The company also disclosed that operators CommuniCare (13%) and Airamid (11%) each exceeded 10% of total investments. The filing also discusses reimbursement risk, including the Medicare SNF final rule for fiscal 2012 that the company says will reduce aggregate Medicare reimbursement to SNFs by $3.87 billion, or 11.1%, a change it believes its operators can absorb.
- 2011-Q1May 9, 2011
Omega Healthcare Investors Quarterly Report for Q1 Ended Mar 31, 2011
Omega Healthcare Investors, Inc. reported a net loss of $5.9 million for the three months ended March 31, 2011, compared with net income of $21.0 million in the same period of 2010. Net loss available to common stockholders was $11.1 million, or $(0.11) per diluted share, versus $18.7 million, or $0.21 per share, a year earlier. The results were driven by a $25.0 million impairment loss on real estate properties, including a $24.4 million charge on the four Connecticut skilled nursing facilities, and by higher depreciation and interest expense following the CapitalSource acquisitions. Total operating revenues rose to $70.5 million from $58.7 million, mainly due to rental income from those acquisitions. Funds from operations available to common stockholders were $14.1 million, compared with $33.4 million in the prior-year period. Balance sheet and capital activity were significant in the quarter. The company redeemed all 4,340 shares of its 8.375% Series D Preferred Stock on March 7, 2011, at $25.21519 per share, funded largely by borrowings of approximately $103 million under its $320 million revolving credit facility. Total stockholders' equity fell to $895.2 million from $1,004.1 million at year-end 2010, and the revolver balance was $69.0 million at quarter end with $251.0 million of availability. Total debt was $1.24 billion. Cash and cash equivalents were $3.4 million. The company also issued 1.3 million common shares under its equity shelf program for net proceeds of $28.1 million, and the Board declared a common dividend of $0.38 per share for the second quarter, up $0.01 from the prior quarter. The portfolio comprised 400 healthcare facilities in 35 states operated by 50 third-party operators, with gross investment of approximately $2.4 billion. The company noted that CommuniCare Health Services accounted for 14% of revenues in the quarter, and that the Connecticut facilities were ordered closed by a court on April 27, 2011, a decision the company intends to appeal. The filing also discusses proposed CMS Medicare rule changes that could reduce operator reimbursement, including an estimated 11.3% decrease in total Medicare reimbursement under one option.